[Event Report] The Second Advisory Board Meeting for the Immunization and Vaccination Policy Promotion Project, “Charting the Way Forward on Immunization Policy: International Trends and the Situation in Japan” (September 15, 2020)
date : 10/6/2020
Tags: Vaccinations
The Health and Global Policy Institute (HGPI) held the second advisory board meeting for the Immunization and Vaccination Policy Promotion Project, “Charting the Way Forward on Immunization Policy: International Trends and the Situation in Japan.”
Following the discussion at the first meeting, the discussion held at the second advisory board meeting focused on rebuilding immunization and vaccination policy with an approach that considers the entire life course.
The discussion addressed the significance, potential, and future of immunization and vaccine policy with a particular focus on people and the life course, including social changes, advances in science and technology, and new lifestyle habits at the individual level.
Starting with leaders from civil society, the meeting included opinion leaders in relevant fields from the government, academia, industry and civil society as well as members of related organizations. They had a constructive and open discussion on approaches to COVID-19 and the effects of vaccine hesitancy on the current situation in Japan on other countries.
Due to the circumstances regarding the COVID-19 pandemic, this meeting was held online.
■Overview
Date & Time: Tuesday, September 15, 2020
Organizer: Health and Global Policy Institute
■Advisory Board Members and Observers (alphabetical order by last name)
Members:
- Kyoko Ama (Former Representative, Ippan Shadan Hojin Shiro Shoni Iryo Mamoro Kodomo-tachi no Kai)
- Hidenori Arai (President, National Center for Geriatrics and Gerontology; Vice President, The Japan Geriatrics Society)
- Satoshi Iwata (Department of Infectious Diseases, National Cancer Center Hospital)
- Isao Miyairi (Medical Director, Department of Infectious Diseases, National Center for Child Health and Development)
- Kuniko Nakayama (Director, My Family Clinic Gamagori, Medical Association Mefa Jinaikai)
- Nobuhiko Okabe (Director General, Kawasaki City Institute for Public Health)
- Akihiko Saitoh (Professor, Department of Pediatrics, Graduate School of Medical and Dental Sciences, Niigata University)
- Akinori Sugaya (Head Physician, Sugaya Children’s Clinic; Director, KNOW VPD Protect Our Children)
- Mugen Ujiie (Director of Travel Clinic, Director of Immunization Support Center, Disease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine (NCGM))
Observers:
- Masayuki Imagawa (Representative Director, Japan Vaccine Industry Association (President))
- Daisaku Sato (Chief Management Officer & Associate Centre Director for Regulatory Science, Pharmaceuticals and Medical Devices Agency, Japan)
Moderator:
- Ryoji Noritake (CEO, Board Member, HGPI)
MC:
- Joji Sugawara (Senior Associate, HGPI)
Secretariat:
- Yui Kohno (Associate, HGPI)
■Related contents held as part of the project (chronological order)
– September 7, 2020 [Recommendations] Proposal on a Global Procurement System for Coronavirus Disease 2019 (COVID-19) Vaccines
Top Research & Recommendations Posts
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Survey Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Preliminary Version) (September 11, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Policy Recommendations] Achieving Equity in Multidisciplinary Pain Treatment and Support Systems for Pain Management (March 31, 2023)
- [Policy Recommendations] Three Necessary Perspectives for Formulating the Basic Plan for the Promotion of Policies on Dementia: Creating a Society That is Inclusive for All People at All Times (April 1, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
Featured Posts
-
2024-09-26
[Registration Open] HGPI Salon Special Edition “The 2024 U.S. Presidential Election’s Impact on Japan’s Healthcare Policies: Future Implications for U.S.-China Relations and U.S.-Japan Cooperation” (October 28, 2024)
-
2024-10-07
[Registration Open] International Dialogue “Fostering Community and Citizen-led Approaches to AMR: Lessons from Antibiotic Smart Sweden” (October 25, 2024)
-
2024-10-07
[Registration Open] Planetary Health Expert Meeting “Building the Future of Healthcare: A Vision for Sustainable and Resilient Health Systems with GGHH” (November 5, 2024)
-
2024-10-09
[Registration Open] HGPI Salon Special Edition “Overcoming Infectious Diseases through Partnership: Focusing on examples of promoting technology transfer of antimicrobial agents” (October 21, 2024)
-
2024-10-09
[Registration Open] (Webinar) The 128th HGPI Seminar “Viewing Healthcare Disparities Through the Lens of Breast Cancer Treatment” (October 29, 2024)